ARDT 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• discussion includes forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never

• materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-

• looking statements. When reviewing the discussion below, you should keep in mind the substantial risks and uncertainties

• that could impact our business. In particular, we encourage you to review the risks and uncertainties described in the section

• This Quarterly Report, including the following discussion, may contain certain "forward-looking statements," as that term is

相对上期删除的文字 · 来源:10-Q · 2025-11-14

• for the year ended December 31, 2024 (the "Annual Report"). The following discussion includes forward-looking statements

• that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our

• results to differ materially from those expressed or implied by such forward-looking statements. When reviewing the

• discussion below, you should keep in mind the substantial risks and uncertainties that could impact our business. In

• particular, we encourage you to review the risks and uncertainties described in the section titled "Risk Factors" included in

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• accompanying condensed consolidated financial statements included elsewhere in this Quarterly Report for more information

• on the interest rate swap agreements. Under the amended October 2021 Agreements, expiring June 30, 2026, we are required

• to make monthly fixed rate payments at annual rates ranging from 1.47% to 1.48% and the counterparties are obligated to

• make monthly floating rate payments to us based on one-month Term SOFR, each subject to a floor of 0.39%. Under the

• February 2025 Agreements, expiring June 26, 2029, we are required to make monthly fixed rate payments at annual rates

相对上期删除的文字 · 来源:10-Q · 2025-11-14

• Financial Statements included within this Quarterly Report for more information on the interest rate swap agreements. Under

• the October 2021 Agreements, expiring June 30, 2026, we are required to make monthly fixed rate payments at annual rates

• ranging from 1.47% to 1.48% and the counterparties are obligated to make monthly floating rate payments to us based on

• one-month Term SOFR, each subject to a floor of 0.39%. On February 5, 2025, we executed new interest rate swap

• agreements with an effective date of June 30, 2025 and expiring June 26, 2029. As of the effective date, the notional amounts

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• Because we provide healthcare services in a highly regulated industry, we have been, are, and expect to continue to be, party

• to various lawsuits and regulatory investigations from time to time. Refer to the "Litigation and Regulatory Matters" section

• of Note 9, Commitments and Contingencies, in the notes to the condensed consolidated financial statements contained

• elsewhere in this Quarterly Report, which is incorporated by reference herein.

相对上期删除的文字 · 来源:10-Q · 2025-11-14

• The information set forth in the “Litigation and Regulatory Matters” section of Note 9, Commitments and Contingencies, in

• the notes to the unaudited condensed consolidated financial statements contained elsewhere in this Quarterly Report is